Peter Rule, MBA
PRI, San Francisco, California

Peter Rule has had a 30 year career leading medical device and diagnostic companies from early start up to beyond an IPO.  In diabetes, Peter led MiniMed as its President and Chief Operating Office and member of the Board of directors (now Medtronic Diabetes Care), establishing the insulin pump market in the US and starting the CGM franchise as a separate team.  He was also a co-founder and Chairman of the Board of Therasense (now Abbott Diabetes Care), establishing the direction for the first ultra-low blood sampling meter (“Freestyle”) and the Navigator CGM.  Other successful companies Peter has led include PercuSurge, the world’s first embolic protection company in interventional cardiology, also purchased by Medtronic, and Ekos Corporation, a drug device delivery company for the treatment of Pulmonary Embolism, DVT, and PAO, purchased by BTG.  Peter has been involved in the design of over 20 clinical trials, and was on the advisory board of the Diabetes Control and Complications Trial (DCCT).  Peter is a named inventor on over 50 US patents.  Recently, Peter led the creation of the first ICU CGM at OptiScan Biomedical, leaving after gaining FDA approval, remaining today a consultant to the company.  Peter currently consults to early stage and established device and diagnostic companies, through his consulting firm PRI.  Clients include breakthrough diabetes companies.  Peter has an undergraduate degree from the University of Southern California and an MBA from Harvard University.